• The Evolving Therapeutic Landscape in Obesity and the Effect on CV Outcomes 

  • Mar 25 2025
  • Duración: 13 m
  • Podcast

The Evolving Therapeutic Landscape in Obesity and the Effect on CV Outcomes 

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this interview, Drs. Richard Chazal and Mikhail Kosiborod explore the rapidly evolving therapeutic landscape of obesity, with a particular focus on the cardiovascular benefits of emerging treatments. They delve into the impact of sodium-glucose co-transporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in enhancing cardiovascular outcomes and improving survival across diverse clinical settings. Their discussion highlights the latest advancements in these therapies, shedding light on their role in reshaping the management of cardiometabolic diseases. 

      Subscribe on Apple Podcasts | Subscribe to ACCEL 

    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre The Evolving Therapeutic Landscape in Obesity and the Effect on CV Outcomes 

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles